Main navigation

• Home
• Our medicines
• Diseases and conditions
• Community support
• Help affording your medicines
• Research & development
• Healthcare professionals
• Careers
• About AstraZeneca US
  • Investors
  • Our company
  • AZ on the issues
  • Responsible business
  • Newsroom
    • Media resources
    • All news
    • Corporate news
    • Financial news
    • Product news
    • Research news
  • US web sites
  • Contact us

You are here

• Home
• About AstraZeneca US
• Newsroom

• News

The following shows headlines of all news articles published within 12-months, starting from most recent.

• Pages
• Previous
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• Next

• • Apr 17, 2009
  • New national online survey says bipolar depressive symptoms have impact on day-to-day tasks as well as social activities  
• • Apr 16, 2009
  • Court grants AstraZeneca temporary restraining order against Apotex in PULMICORT RESPULES® patent litigation  
• • Apr 15, 2009
  • National survey reveals gap in “uncontrolled asthma” knowledge - putting asthma patients at risk for serious health consequences  
• • Apr 9, 2009
  • FDA Advisory Committee recommendation on SEROQUEL XR Supplemental New Drug Applications  
• • Apr 6, 2009
  • AstraZeneca receives FDA Complete Response Letter on SYMBICORT for the treatment of asthma in children 6 to 11 years old  
• • Apr 3, 2009
  • FDA Advisory Committee documents for SEROQUEL XR available on AstraZeneca web site  
• • Apr 3, 2009
  • AstraZeneca’s David Brennan elected PhRMA board chairman  
• • Apr 3, 2009
  • Public and private organizations join forces to help the uninsured connect to free or low-cost health services  
• • Mar 30, 2009
  • Patients receiving hemodialysis for treatment of end stage renal disease did not benefit from statin therapy in the AURORA study  
• • Mar 29, 2009
  • CRESTOR® reduced risk of blood clots in the veins  

• Pages
• Previous
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• Next

Page tools

• Print
• Bookmark this page
• Subscribe to RSS news feed